• NotiPark

  Participated · Equity · Jun 2026

  NotiPark builds a system that automatically starts a parking session when a user parks and stops it when they leave, charging only for the time used. The product relies on proprietary, highly precise localization technology to enable that automated user experience. The team, led by Jeremy Skowronek, is engaging with cities and operators and reports early market traction. The company is already in discussions with more than 30 cities across Belgium, France and the Netherlands and is building partnerships with leading mobility and parking operators. The article does not disclose revenue, user counts, founding year, or location.

• FlickArt

  Participated · Seed · May 2026

  Flick builds an AI-native film production platform designed to combine generative models with real film production through non-linear workflows and filmic control features. The product targets filmmakers who want aesthetic control, iterative creative tools and the ability to direct AI-generated films without relying on raw prompting. Flick is led by co-founders Zoey Zhang, an award-winning filmmaker, and Ray Wang, a founding engineer of Instagram Stories. The company runs the Flick Filmmaker Residency to support emerging AI-native filmmakers; the first cohort debuts with over 10 AI-based short films shown at festivals including Cinequest, MIT and the Omni AI Film Festival. Flick plans to use its recent seed financing to accelerate product development, expand core creative tools, and grow its filmmaker community.

• Novoflow

  Participated · Seed · Feb 2026

  Novoflow is an artificial-intelligence healthcare startup founded by 19-year-old Mathieu Rihet and 18-year-old Georges Casassovic after both dropped out of school to focus on the venture. The company is building a virtual employee—an AI agent that automates core clinic operations such as appointment recovery, intelligent scheduling, voice-based call handling, documentation, and billing while linking disparate electronic medical record platforms. Operated from a combined live-and-work base in San Francisco, the lean team currently includes junior engineers and an account executive, with plans to hire two more engineers and an additional sales representative. Novoflow has been accepted into Y Combinator’s 2025 batch, providing external validation and ecosystem access. The founders’ personal experiences with clinical inefficiencies and neurological health challenges inform the product roadmap, which ultimately aims to cover the full spectrum of clinic management from scheduling to prescription fulfillment. Proceeds from the recent financing are earmarked for product development and go-to-market expansion.

• Freya

  Participated · Seed · Nov 2025

  Freya is a San Francisco–based startup that develops advanced AI agents able to conduct phone conversations with natural flow, realistic tone of voice, and deep contextual understanding. The platform automates customer interactions, extracts information from documents, generates call analytics, and connects to CRM and other operational systems. Deployable in both cloud and on-premise environments, it is tailored for financial services, insurance, and general customer-support use cases. Backed by Y Combinator (YC S25), the company has rapidly expanded its commercial footprint and now serves clients across the United States, Europe, and Turkey. Freya’s technology aims to reduce labor costs and improve service quality for contact centers. The firm recently secured $3.5 million in new capital, strengthening its financial position to continue product enhancement and market penetration.

• Every Health

  Participated · Seed · Oct 2025

  Every Health is a German digital-health startup building the first virtual clinic in Europe devoted to LGBTQ+ and broader sexual-health services. Its platform offers end-to-end care pathways that include at-home testing, online consultations, e-prescriptions and discreet medication delivery, all supported by a network of partner doctors, pharmacies and laboratories. In its first year of operation the company has already served thousands of users across Germany, validating demand for culturally competent, judgment-free healthcare. While initially focused on LGBTQ+-specific needs such as PrEP access and gender-affirming care, the service is also positioning itself as a mainstream sexual-health provider to anyone facing stigma or geographic barriers in traditional systems. Management points to a €150 billion annual LGBTQ+ healthcare spend in Europe and data showing 46 % of queer patients hide their identity from clinicians, underscoring the market gap. Proceeds from the latest financing will fund new remote diagnostics and treatment pathways and underpin expansion to additional European countries. The company has not disclosed revenue figures but emphasizes rapid user growth and partnerships as early traction indicators.

No current team members are available.